Changes of structural, magnetic and spectroscopic properties of microencapsulated iron sucrose nanoparticles in saline

• Sabina Lewińska,
• Pavlo Aleshkevych,
• Roman Minikayev,
• Anna Bajorek,
• Mateusz Dulski,
• Krystian Prusik,
• Tomasz Wojciechowski and
• Anna Ślawska-Waniewska

Beilstein J. Nanotechnol. 2025, 16, 762–784, doi:10.3762/bjnano.16.59

Aprepitant-loaded solid lipid nanoparticles: a novel approach to enhance oral bioavailability

• Mazhar Hussain,
• Muhammad Farooq,
• Muhammad Asad Saeed,
• Muhammad Ijaz,
• Sherjeel Adnan,
• Zeeshan Masood,
• Muhammad Waqas,
• Wafa Ishaq and
• Nabeela Ameer

Beilstein J. Nanotechnol. 2025, 16, 652–663, doi:10.3762/bjnano.16.50

• analysis. APT-loaded SLNs were prepared by the precipitation method and characterized by physicochemical studies including particle size and zeta potential measurements, drug content, encapsulation efficiency and solubility studies, Fourier-transform infrared spectroscopy (FTIR), scanning electron

• encapsulation efficiency The drug content of SLNs formulations ranged from 16.95% ± 0.76% to 96.75% ± 0.24%; the highest APT content was obtained in APT-CD-NP4. The loss of the drug can be attributed to the lyophilization. However, there was no change in color or aggregation observed. Dispersions of lyophilized

• SLN formulations in distilled water exhibited a homogeneous white color. The encapsulation efficacy of the SLNs formulations was in the range of 25.33% ± 0.89% to 80.55% ± 0.15%. A higher content of β-CD in the formulation enhanced the encapsulated amount of APT. The hydrophobic structure of β-CD

Polyurethane/silk fibroin-based electrospun membranes for wound healing and skin substitute applications

• Iqra Zainab,
• Zohra Naseem,
• Syeda Rubab Batool,
• Muhammad Waqas,
• Ahsan Nazir and
• Muhammad Anwaar Nazeer

Beilstein J. Nanotechnol. 2025, 16, 591–612, doi:10.3762/bjnano.16.46

• applications without affecting the structure or bioactivity. The effective encapsulation of STZ was confirmed by FTIR, and the nanofibers showed high cytocompatibility in cell viability tests. STZ was released from nanofibers over 6 h, and its antibacterial activity was demonstrated through the formation of a

Synthetic-polymer-assisted antisense oligonucleotide delivery: targeted approaches for precision disease treatment

• Ana Cubillo Alvarez,
• Dylan Maguire and
• Ruairí P. Brannigan

Beilstein J. Nanotechnol. 2025, 16, 435–463, doi:10.3762/bjnano.16.34

• ) modified with 3-mercaptopropyl amidine and 2-thiolaneimine (Figure 4). This design allowed for stable encapsulation of a LNA-modified gapmer structure with a phosphorothioate linkage backbone targeting the MALAT1 gene. The presence of disulfide cross-links in the micelle core was found to enhance particle

Development of a mucoadhesive drug delivery system and its interaction with gastric cells

• Ahmet Baki Sahin,
• Serdar Karakurt and
• Deniz Sezlev Bilecen

Beilstein J. Nanotechnol. 2025, 16, 371–384, doi:10.3762/bjnano.16.28

• positive charge. A peptide, as a model drug, was loaded onto the nanoparticles with an encapsulation efficiency of 58%. The release of the model drug from the delivery system was pH-independent and lasted for 7 days. The periodic acid–Schiff stain assay indicated 69% mucin interaction for the nanoparticles

• , effective encapsulation, pH-responsive release, and enhanced stability. Eudragit RS 100 is a copolymer of ethyl acrylate, methyl methacrylate, and a low proportion of methacrylic acid ester with quaternary ammonium groups. It is known for its mucoadhesive properties [16], which are independent of the site

• adhere to the mucosa. The size of the microspheres, from which the drug was released over a period of 24 h, was in the range of 800–900 µm [26]. Although particulate systems with larger sizes could be advantageous in terms of higher encapsulation efficiency and slower release, they would have a reduced

Fabrication and evaluation of BerNPs regarding the growth and development of Streptococcus mutans

• Tuyen Huu Nguyen,
• Hong Thanh Pham,
• Kieu Kim Thanh Nguyen,
• Loan Hong Ngo,
• Anh Ngoc Tuan Mai,
• Thu Hoang Anh Lam,
• Ngan Thi Kim Phan,
• Dung Tien Pham,
• Duong Thuy Hoang,
• Thuc Dong Nguyen and
• Lien Thi Xuan Truong

Beilstein J. Nanotechnol. 2025, 16, 308–315, doi:10.3762/bjnano.16.23

• , several methods of berberine encapsulation, berberine carrier materials, and berberine microemulsions have also been studied to improve the bioavailability and clinical applicability of berberine [9][13][14][15][16][17]. Although many studies have evaluated the antibacterial activity of berberine, there

Enhancing mechanical properties of chitosan/PVA electrospun nanofibers: a comprehensive review

• Nur Areisman Mohd Salleh,
• Amalina Muhammad Afifi,
• Fathiah Mohamed Zuki and
• Hanna Sofia SalehHudin

Beilstein J. Nanotechnol. 2025, 16, 286–307, doi:10.3762/bjnano.16.22

• layering fibers upon fibers through multiple steps, as shown in Figure 6. The functionality of the overall structure depends on the different properties exhibited by each layer. In bioactive encapsulation and controlled release applications, for example, multilayered membranes can be used to regulate the

Recent advances in photothermal nanomaterials for ophthalmic applications

• Jiayuan Zhuang,
• Linhui Jia,
• Chenghao Li,
• Rui Yang,
• Jiapeng Wang,
• Wen-an Wang,
• Heng Zhou and
• Xiangxia Luo

Beilstein J. Nanotechnol. 2025, 16, 195–215, doi:10.3762/bjnano.16.16

• molecule dyes can be modulated by intramolecular rotation or intermolecular interactions [63]. By using nanocarrier encapsulation and self-assembly strategies, the water solubility and stability of organic small molecule dyes can be improved, and photobleaching can be reduced [64]. Materials that undergo

A nanocarrier containing carboxylic and histamine groups with dual action: acetylcholine hydrolysis and antidote atropine delivery

• Elina E. Mansurova,
• Andrey A. Maslennikov,
• Anna P. Lyubina,
• Alexandra D. Voloshina,
• Irek R. Nizameev,
• Marsil K. Kadirov,
• Anzhela A. Mikhailova,
• Polina V. Mikshina,
• Albina Y. Ziganshina and
• Igor S. Antipin

Beilstein J. Nanotechnol. 2025, 16, 11–24, doi:10.3762/bjnano.16.2

• , encapsulation of the antidote, acetylcholine hydrolysis, and antidote release. Keywords: acetylcholine; antidote delivery; artificial cholinesterase; atropine; nanocarrier; resorcinarene; Introduction Cholinergic toxicity results from an excessive quantity of acetylcholine (ACh), causing muscle cramps, nausea

• disintegrates the nanocarrier, leading to the release of Atr (Scheme 1). This paper discusses the synthesis of the Atr nanocarrier, its physicochemical and biological properties, the encapsulation of Atr into the nanocarrier cavity, ACh hydrolysis, nanocarrier degradation, and Atr release under the ACh action

• , resulting in the decomposition of the polymer. Fluorescein encapsulation and release under the influence of ACh To verify the degradation of p(Hist-CA) by ACh, fluorescein (Fl) was encapsulated into the nanocarrier cavity. Initially, 5 mg of Fl was dissolved in 15–20 mL of ethanol. Next, 7.3 μL of TO was

Mechanistic insights into endosomal escape by sodium oleate-modified liposomes

• Ebrahim Sadaqa,
• Satrialdi,
• Fransiska Kurniawan and
• Diky Mudhakir

Beilstein J. Nanotechnol. 2024, 15, 1667–1685, doi:10.3762/bjnano.15.131

• complexes with liposomal components, enhancing both liposome stability and drug encapsulation. To gain deeper insight into the mechanisms underpinning SO’s potential as an endosomal escape agent, molecular dynamics (MD) simulations have emerged as an indispensable computational tool. These simulations

Biomimetic nanocarriers: integrating natural functions for advanced therapeutic applications

• Hugo Felix Perini,
• Beatriz Sodré Matos,
• Carlo José Freire de Oliveira and
• Marcos Vinicius da Silva

Beilstein J. Nanotechnol. 2024, 15, 1619–1626, doi:10.3762/bjnano.15.127

• advancements nanocarriers have brought to medical sciences, particularly in cancer treatment, several challenges remain for their widespread application. Issues such as cytotoxicity, difficulties in management, encapsulation, and in vivo release pose barriers to the application of nanocarriers [16][17]. In

• nonpermissive characteristics at the barrier [69]. Polymeric nanoparticles, as well as those based on lipids and inorganic materials, are extensively studied for Alzheimer's disease treatment due to their tissue selectivity, potential circulation time, encapsulation capacity, and, importantly, their ability to

Natural nanofibers embedded in the seed mucilage envelope: composite hydrogels with specific adhesive and frictional properties

• Agnieszka Kreitschitz and
• Stanislav N. Gorb

Beilstein J. Nanotechnol. 2024, 15, 1603–1618, doi:10.3762/bjnano.15.126

• encapsulation of medical substances. A very important advantage of diaspore mucilages are their antimicrobial properties [105][106][110][111]. Phenolic compounds are secondary plant metabolites, which demonstrate a wide range of structures, from simple molecules to polymeric compounds. They can be produced in

• production of biofilms, encapsulation, or lubricants with medical application [106][110][111][116][117]. Our findings may also help to design pathogen-resistant lubricating biomaterials with low friction, which can be achieved in rather simply way by adding phenolic substances to the medical hydrogels [98

Polymer lipid hybrid nanoparticles for phytochemical delivery: challenges, progress, and future prospects

• Iqra Rahat,
• Pooja Yadav,
• Aditi Singhal,
• Mohammad Fareed,
• Jaganathan Raja Purushothaman,
• Mohammed Aslam,
• Raju Balaji,
• Sonali Patil-Shinde and
• Md. Rizwanullah

Beilstein J. Nanotechnol. 2024, 15, 1473–1497, doi:10.3762/bjnano.15.118

• . We discuss the obstacles in the conventional delivery of phytochemicals, the fundamental architecture of PLHNPs, and the types of PLHNPs, highlighting their ability to improve encapsulation efficiency, stability, and controlled release of the encapsulated phytochemicals. In addition, the surface

• polyethylene glycol (PEG), poly(lactic-co-glycolic acid) (PLGA), polycaprolactone (PCL), and chitosan (CHS), provides structural integrity, controlled release properties, and protection against premature degradation [14][15]. This hybrid structure improves the encapsulation efficiency of phytochemicals/drugs

• include their small particle size, high encapsulation efficiency, enhanced stability, and improved dissolution in harsh gastrointestinal (GI) fluids. Following oral administration, PLHNPs demonstrate superior intestinal absorption and bioavailability, attributed to their enhanced stability and dissolution

Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals

• Selin Akpinar Adscheid,
• Akif E. Türeli,
• Nazende Günday-Türeli and
• Marc Schneider

Beilstein J. Nanotechnol. 2024, 15, 1400–1414, doi:10.3762/bjnano.15.113

• opportunity to modify the release profile of the drugs, enhance targeting efficiency, and improve nasal permeation during intranasal administration [21][22][23][24]. In general, the encapsulation of active pharmaceutical ingredients (APIs) into mucoadhesive DDSs can mitigate rapid mucociliary clearance [25

• al. reported the encapsulation of ropinirole hydrochloride (RH), an anti-Parkinson drug, into chitosan-coated PLGA NPs by the nanoprecipitation method to enhance drug delivery through the nasal mucosa. The researchers assessed the mucoadhesive properties by observing the ability of the NPs to adsorb

• showed higher encapsulation efficiency for the positively charged ghrelin at pH 7.4, indicating that the choice of the anionic/cationic liposomes should be based on the desired application as well as the encapsulated substance. Moreover, a chitosan chloride coating increased mucin adsorption by

Enhanced catalytic reduction through in situ synthesized gold nanoparticles embedded in glucosamine/alginate nanocomposites

• Chi-Hien Dang,
• Le-Kim-Thuy Nguyen,
• Minh-Trong Tran,
• Van-Dung Le,
• Nguyen Minh Ty,
• T. Ngoc Han Pham,
• Hieu Vu-Quang,
• Tran Thi Kim Chi,
• Tran Thi Huong Giang,
• Nguyen Thi Thanh Tu and
• Thanh-Danh Nguyen

Beilstein J. Nanotechnol. 2024, 15, 1227–1237, doi:10.3762/bjnano.15.99

• ) and the cross-linker [17]. These materials find wide applications in drug delivery [18] and the encapsulation of nanometals [19][20]. Reduction of metallic ions can be achieved using various agents, including plant extracts [21]. This reduction typically involves two steps, namely, the loading of

Synthesis, characterization and anticancer effect of doxorubicin-loaded dual stimuli-responsive smart nanopolymers

• Ömür Acet,
• Pavel Kirsanov,
• Burcu Önal Acet,
• Inessa Halets-Bui,
• Dzmitry Shcharbin,
• Şeyda Ceylan Cömert and
• Mehmet Odabaşı

Beilstein J. Nanotechnol. 2024, 15, 1189–1196, doi:10.3762/bjnano.15.96

• . Characterizations of the synthesized nanostructures were carried out including zeta potential measurements, Fourier-transform infrared spectroscopy, and scanning electron microscopy. The loading capacity of the nanopolymers for DOX was investigated, and encapsulation and release studies were carried out. In a final

• because of fast filling of the adsorption sites. In conclusion, DOX loading onto the SNPs was accomplished successfully. In previous studies conducted by our group on the carrying capacity of nanostructures, we obtained comparable results [20][24][37]. Encapsulation and release studies of DOX encapsulated

• SNPs The encapsulation and release behaviors of SNPs are extremely important for both efficient delivery and release. To evaluate the release properties of the synthesized SNPs, a PBS solution with a DOX concentration of 5 µM at pH 7.0 was prepared. The methodology for incorporating DOX into SNPs is

Recent updates in applications of nanomedicine for the treatment of hepatic fibrosis

• Damai Ria Setyawati,
• Fransiska Christydira Sekaringtyas,
• Riyona Desvy Pratiwi,
• A’liyatur Rosyidah,
• Rohimmahtunnissa Azhar,
• Nunik Gustini,
• Gita Syahputra,
• Idah Rosidah,
• Etik Mardliyati,
• Tarwadi and
• Sjaikhurrizal El Muttaqien

Beilstein J. Nanotechnol. 2024, 15, 1105–1116, doi:10.3762/bjnano.15.89

• as an absorption enhancer [51]. The therapeutic potential of curcumin using nanoformulations was reviewed by several researchers, summarizing recent curcumin encapsulation works on various NP platforms (liposomes, solid lipid NPs, micelles, and polymeric NPs) [52][53]. For example, polymeric

• encapsulation of curcumin in the phosphatidylserine nanocarrier improved its in vivo retention time, while free curcumin was quickly cleared from the body. As a consequence of the altered pharmacokinetics of the curcumin nanocarrier, the accumulation of curcumin in the liver was also enhanced, confirming its

Unveiling the potential of alginate-based nanomaterials in sensing technology and smart delivery applications

• Shakhzodjon Uzokboev,
• Khojimukhammad Akhmadbekov,
• Ra’no Nuritdinova,
• Salah M. Tawfik and
• Yong-Ill Lee

Beilstein J. Nanotechnol. 2024, 15, 1077–1104, doi:10.3762/bjnano.15.88

• evaporation, and nanoprecipitation. Advances in alginate-based nanoparticle design have resulted in increased drug encapsulation efficiency, allowing for larger drug payloads within the nanoparticles. Biopolymeric nanoparticles have become the most commonly used nanoparticle DDSs in recent years. The

• their unique characteristics (Table 1), including a surface that easily adheres to the intestinal epithelium, drug encapsulation without the use of organic solvents, good absorption properties, and a low level of toxicity [76]. The adherence to the intestinal epithelium is particularly beneficial for

• drugs that need to be delivered to the gastrointestinal tract, as it ensures maximum absorption and therapeutic efficacy. Drug encapsulation without organic solvents is advantageous because organic solvents can be toxic and pose a risk to patient safety. The nanoparticles have a large surface area-to

Electrospun polysuccinimide scaffolds containing different salts as potential wound dressing material

• Veronika Pálos,
• Krisztina S. Nagy,
• Rita Pázmány,
• Krisztina Juriga-Tóth,
• Bálint Budavári,
• Judit Domokos,
• Dóra Szabó,
• Ákos Zsembery and
• Angela Jedlovszky-Hajdu

Beilstein J. Nanotechnol. 2024, 15, 781–796, doi:10.3762/bjnano.15.65

• antibacterial properties is limited due to the encapsulation of certain nanoparticles within the fibers [23]. One of the most common approaches is the introduction of antibiotics. However, with the misuse and/or overuse of these types of drugs, there is the risk of antibiotic resistance (AMR), which is one of

Radiofrequency enhances drug release from responsive nanoflowers for hepatocellular carcinoma therapy

• Yanyan Wen,
• Ningning Song,
• Yueyou Peng,
• Weiwei Wu,
• Qixiong Lin,
• Minjie Cui,
• Rongrong Li,
• Qiufeng Yu,
• Sixue Wu,
• Yongkang Liang,
• Wei Tian and
• Yanfeng Meng

Beilstein J. Nanotechnol. 2024, 15, 569–579, doi:10.3762/bjnano.15.49

• this percentage increased to 42% at pH 5.0 (Figure 4a). These results indicate that RF heating enhances degradation of NFs. Due to their structure, CUR-Fe@MnO2 NFs efficiently increased the drug loading efficiency (DLE) of CUR and improved its stability. The drug encapsulation efficiency (DEE) and DLE

On the additive artificial intelligence-based discovery of nanoparticle neurodegenerative disease drug delivery systems

• Shan He,
• Julen Segura Abarrategi,
• Harbil Bediaga,
• Sonia Arrasate and
• Humberto González-Díaz

Beilstein J. Nanotechnol. 2024, 15, 535–555, doi:10.3762/bjnano.15.47

• encapsulation, a larger NP size (70 nm) is needed. However, when NPs serve as carriers by binding drug molecules to their surface, a larger free surface area is required; therefore, the optimal size would be 20 nm [92]. This principle suggests that a high number of the NPs in our database are proper drug

• delivery carriers by drug encapsulation. Thus, the design of new N2D3Ss based on multiple preclinical assays of NP cytotoxicity and NDDs has been carried out successfully. This database involves a high structural and biological diversity, which may help to distinguish active from non-active N2D3Ss

Vinorelbine-loaded multifunctional magnetic nanoparticles as anticancer drug delivery systems: synthesis, characterization, and in vitro release study

• Zeynep Özcan and
• Afife Binnaz Hazar Yoruç

Beilstein J. Nanotechnol. 2024, 15, 256–269, doi:10.3762/bjnano.15.24

• efficacy. The application of vinorelbine tartrate is limited because of its dose-related toxicity to the nervous, pulmonary, and gastrointestinal systems and reduced absorption when taken orally [33]. Encapsulation studies specifically aim to create a controlled drug delivery system to reduce existing side

• concentrations. The generated calibration curve was utilized to determine the cumulative drug release and encapsulation efficiency. Equation 6 represents the calibration curve derived from absorbance readings: The entrapment efficiency of VNB onto the polydopamine-coated iron oxide nanoparticles (PDA/Fe3O4 NPs

Nanocarrier systems loaded with IR780, iron oxide nanoparticles and chlorambucil for cancer theragnostics

• Phuong-Thao Dang-Luong,
• Hong-Phuc Nguyen,
• Loc Le-Tuan,
• Xuan-Thang Cao,
• Vy Tran-Anh and
• Hieu Vu Quang

Beilstein J. Nanotechnol. 2024, 15, 180–189, doi:10.3762/bjnano.15.17

• urinary obstruction [14]. In another study, PLGA SPIONs could transport chemotherapeutic agents for cancer treatment and diagnosis [15]. Therefore, the combination of PLGA and SPIONs promises a useful theragnostic system in our study. In addition to the encapsulation of SPIONs in PLGA employed for

• and IR783 are also promising diagnostic choices. Encapsulation of IR780 in nanoparticles can be used for imaging and photothermal, photodynamic, and combinatorial cancer therapies [20][21][22]. IR780 is also utilized in PEG-PLA nanoparticles for photodynamic therapy of human breast cancer cells [23

• particle [25][26]. PLGA is one of the finest materials for transporting chemotherapy drugs. PLGA transports not only hydrophobic but also hydrophilic drugs. The encapsulation of chemotherapeutics in PLGA nanoparticles has been extensively studied. PLGA has been loaded with doxorubicin, for instance, for

Development and characterization of potential larvicidal nanoemulsions against Aedes aegypti

• Jonatas L. Duarte,
• Leonardo Delello Di Filippo,
• Anna Eliza Maciel de Faria Mota Oliveira,
• Rafael Miguel Sábio,
• Gabriel Davi Marena,
• Tais Maria Bauab,
• Cristiane Duque,
• Vincent Corbel and
• Marlus Chorilli

Beilstein J. Nanotechnol. 2024, 15, 104–114, doi:10.3762/bjnano.15.10

• concentrations (5 mg/L and 25 mg/L) compared to free cymene. This suggests that the encapsulation influences the bioactivity, potentially because of improved dispersion and controlled release of cymene. Similarly, free myrcene exhibited a concentration-dependent efficacy. Myrcene NEs consistently outperformed

• at the tested concentrations. Conclusion The rHLB values for cymene and myrcene were 15 and 16, respectively. These formulations demonstrated good colloidal stability over 60 days with stable values of size, PdI, and zeta potential. In vitro release studies demonstrated that the encapsulation of

Curcumin-loaded nanostructured systems for treatment of leishmaniasis: a review

• Douglas Dourado,
• Thayse Silva Medeiros,
• Éverton do Nascimento Alencar,
• Edijane Matos Sales and
• Fábio Rocha Formiga

Beilstein J. Nanotechnol. 2024, 15, 37–50, doi:10.3762/bjnano.15.4

• , lipid nanoparticles, nano- and microemulsions, liposomes, or metallic nanoparticles [68]. Costa-Lima and colleagues incorporated bisnaphthalimidopropyldiaaminooctane (BNIPDaoct) into PLGA polymeric nanoparticles and obtained particles with sizes around 150 nm, with encapsulation efficiency around 90

• ursolic acid (UA) functionalized with N-octyl chitosan. The NLC were approximately 143 nm of the hydrodynamic diameter. The authors also found encapsulation and drug-load efficiencies of 88.63 ± 2.70% and 12.05 ± 0.54%, respectively [70]. They evaluated the antileishmanial potential of the nanosystems